Immunohistochemical markers used for diagnostic purposes of melanoma, e.g., HMB45 (gp100), tyrosinase, and Melan-A, are also often expressed in OcM and, thus, not able to distinguish between the different melanoma subtypes. Here, PMEL is linked to melanoma.